R. Hasseli

发表

Adipokines and Autoimmunity in Inflammatory Arthritis

U. Müller-Ladner, E. Neumann, U. Lange, 2021, Cells.

Skeletal muscle provides the immunological micro-milieu for specific plasma cells in anti-synthetase syndrome-associated myositis

J. Lünemann, H. Wiendl, S. Meuth, 2022, Acta Neuropathologica.

Interactions between rheumatoid arthritis synovial fibroblast migration and endothelial cells

U. Schumacher, U. Müller-Ladner, T. Gehrke, 2018, Immunology and cell biology.

Systemic versus local adipokine expression differs in a combined obesity and osteoarthritis mouse model

U. Müller-Ladner, G. Schett, E. Roeb, 2021, Scientific Reports.

Environmental and societal factors associated with COVID-19-related death in people with rheumatic disease: an observational study

S. Horton, M. Gianfrancesco, J. Yazdany, 2022, The Lancet Rheumatology.

Adipokines and Inflammation Alter the Interaction Between Rheumatoid Arthritis Synovial Fibroblasts and Endothelial Cells

U. Müller-Ladner, I. Tarner, S. Rehart, 2020, Frontiers in Immunology.

Targeting Activated Synovial Fibroblasts in Rheumatoid Arthritis by Peficitinib

U. Müller-Ladner, S. Rehart, E. Neumann, 2019, Front. Immunol..

The activin-follistatin anti-inflammatory cycle is deregulated in synovial fibroblasts

U. Müller-Ladner, T. Pap, I. Tarner, 2019, Arthritis Research & Therapy.

Development of a Prediction Model for COVID‐19 Acute Respiratory Distress Syndrome in Patients With Rheumatic Diseases: Results From the Global Rheumatology Alliance Registry

M. Gianfrancesco, J. Yazdany, G. Schmajuk, 2022, ACR open rheumatology.

National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRD

H. Lorenz, A. Regierer, R. Voll, 2020, RMD Open.

[A cross sectional study on patients with inflammatory rheumatic diseases in terms of their compliance to their immunsuppressive medication during COVID-19 pandemic].

U. Müller-Ladner, S. Wassenberg, A. Schwarting, 2020, Zeitschrift fur Rheumatologie.

Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19

L. Trupin, E. Soriano, M. Gianfrancesco, 2021, JAMA network open.

Small fiber involvement is independent from clinical pain in late-onset Pompe disease

K. Claeys, W. Löscher, A. Rosenbohm, 2022, Orphanet Journal of Rare Diseases.

Characteristics and Outcomes of People With Gout Hospitalized Due to COVID‐19: Data From the COVID‐19 Global Rheumatology Alliance Physician‐Reported Registry

M. Gianfrancesco, J. Yazdany, L. Carmona, 2022, ACR open rheumatology.

Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology Alliance

G. Alarcón, M. Gianfrancesco, J. Yazdany, 2022, Annals of the Rheumatic Diseases.

NK Cell Patterns in Idiopathic Inflammatory Myopathies with Pulmonary Affection

H. Wiendl, S. Meuth, W. Stenzel, 2021, Cells.

Skeletal muscle provides the immunological micro-milieu for specific plasma cells in anti-synthetase syndrome-associated myositis

J. Lünemann, H. Wiendl, S. Meuth, 2022, Acta Neuropathologica.

Factors associated with severe COVID-19 in people with idiopathic inflammatory myopathy: results from the COVID-19 Global Rheumatology Alliance physician-reported registry

M. Gianfrancesco, J. Yazdany, L. Carmona, 2022, RMD Open.

[Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in the context of the SARS-CoV‑2/COVID‑19 pandemic, including recommendations for COVID‑19 vaccination].

R. Fischer-Betz, Matthias Schneider, F. Moosig, 2021, Zeitschrift fur Rheumatologie.

Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry

L. Trupin, M. Gianfrancesco, J. Yazdany, 2021, Annals of the Rheumatic Diseases.

Characteristics associated with poor COVID-19 outcomes in people with psoriasis, psoriatic arthritis and axial spondyloarthritis: data from the COVID-19 PsoProtect and Global Rheumatology Alliance physician-reported registries

J. Yazdany, L. Carmona, N. Dand, 2023, Annals of the Rheumatic Diseases.

Free Fatty Acids in Bone Pathophysiology of Rheumatic Diseases

C. Culmsee, U. Müller-Ladner, M. Zaiss, 2019, Front. Immunol..

Older age, comorbidity, glucocorticoid use and disease activity are risk factors for COVID-19 hospitalisation in patients with inflammatory rheumatic and musculoskeletal diseases

H. Lorenz, A. Regierer, R. Voll, 2021, RMD Open.

TNFi is associated with positive outcome, but JAKi and rituximab are associated with negative outcome of SARS-CoV-2 infection in patients with RMD

Andreas Krause, Hanns-Martin Lorenz, A. Regierer, 2021, RMD Open.

Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry

L. Trupin, M. Gianfrancesco, J. Yazdany, 2021, Annals of the Rheumatic Diseases.

Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort study

S. Horton, M. Gianfrancesco, J. Yazdany, 2021, The Lancet Rheumatology.

Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab

A. Skapenko, H. Schulze-Koops, R. Hasseli, 2020, Annals of the Rheumatic Diseases.

Characteristics and outcomes of SARS-CoV-2 breakthrough infections among double-vaccinated and triple-vaccinated patients with inflammatory rheumatic diseases

Andreas Krause, Hanns-Martin Lorenz, A. Regierer, 2023, RMD Open.

A survey to evaluate knowledge, perceptions and attitudes toward COVID-19 vaccinations among rheumatologists in Germany

Andreas Krause, U. Müller-Ladner, H. Lorenz, 2021, Rheumatology International.

Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in the context of the SARS-CoV-2/COVID-19 pandemic, including recommendations for COVID-19 vaccination

Andreas Krause, R. Fischer-Betz, Matthias Schneider, 2021, Zeitschrift für Rheumatologie.

OP0283 DOES TNF-INHIBITION DECREASE THE RISK OF SEVERE COVID-19 IN RMD-PATIENTS?

Andreas Krause, U. Müller-Ladner, A. Regierer, 2021, Annals of the Rheumatic Diseases.

Do patients with rheumatoid arthritis show a different course of COVID-19 compared to patients with spondyloarthritis?

U. Müller-Ladner, H. Lorenz, R. Voll, 2021, Clinical and experimental rheumatology.

Tetraspanin CD82 affects migration, attachment and invasion of rheumatoid arthritis synovial fibroblasts

S. Rehart, E. Neumann, U. Mueller-Ladner, 2018, Annals of the rheumatic diseases.

OP0249 CHARACTERISTICS ASSOCIATED WITH POOR COVID-19 OUTCOMES IN PEOPLE WITH PSORIASIS AND SPONDYLOARTHRITIS: DATA FROM THE COVID-19 PsoProtect AND GLOBAL RHEUMATOLOGY ALLIANCE PHYSICIAN-REPORTED REGISTRIES

M. Gianfrancesco, J. Yazdany, J. Hausmann, 2022, Annals of the Rheumatic Diseases.